Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 80

Results For "Research"

2024 News Found

Agilent announces LC/TQ and LC/Q-TOF mass spectrometry solutions
News | June 06, 2023

Agilent announces LC/TQ and LC/Q-TOF mass spectrometry solutions

The superior Agilent 6495 Triple Quadrupole LC/MS (LC/TQ) System is ideal for demanding and challenging targeted analysis applications requiring the highest analytical sensitivity


Keytruda+ chemotherapy improves overall survival versus chemotherapy alone for unresectable advanced pleural mesothelioma
Diagnostic Center | June 05, 2023

Keytruda+ chemotherapy improves overall survival versus chemotherapy alone for unresectable advanced pleural mesothelioma

In Phase 3 CCTG IND.227/KEYNOTE-483 trial, KEYTRUDA plus chemotherapy also demonstrated statistically significant improvements in PFS and ORR compared to chemotherapy alone


International cooperation must to advance vaccine development for emerging pathogens: Health Minister Mandaviya
Policy | June 04, 2023

International cooperation must to advance vaccine development for emerging pathogens: Health Minister Mandaviya

The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective


Glenmark sets GHG emission targets for FY2035
Sustainability | June 01, 2023

Glenmark sets GHG emission targets for FY2035

The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock


Synexa Joins CEPI in advancing global epidemic preparedness and response
News | May 31, 2023

Synexa Joins CEPI in advancing global epidemic preparedness and response

Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness


Janssen Tremfya excels as psoriasis treatment, outshining IL-17s, says GlobalData
News | May 31, 2023

Janssen Tremfya excels as psoriasis treatment, outshining IL-17s, says GlobalData

The drug exhibited greater treatment persistence and control of moderate-to-severe PsO symptoms compared to secukinumab and ixekizumab


Wockhardt’s Q4 FY23 three fold jump in EBITDA over Q4 FY22
News | May 29, 2023

Wockhardt’s Q4 FY23 three fold jump in EBITDA over Q4 FY22

Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239


We need to focus on quality and affordable manufacturing: Mandaviya
Policy | May 29, 2023

We need to focus on quality and affordable manufacturing: Mandaviya

Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities


Roquette, Beren Therapeutics join forces to advance cyclodextrin technologies
News | May 29, 2023

Roquette, Beren Therapeutics join forces to advance cyclodextrin technologies

Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.